scholarly journals Universal CMV Prophylaxis Mitigates the Risks of Basiliximab Induction in Heart Transplant Recipients at Intermediate Risk (R+) for Post-Transplant CMV Complications

2021 ◽  
Vol 40 (4) ◽  
pp. S117
Author(s):  
T. Alexy ◽  
A. Morris ◽  
M. Flattery ◽  
J. Ortega-Legaspi ◽  
A. Devore ◽  
...  
2000 ◽  
Vol 69 (Supplement) ◽  
pp. S236
Author(s):  
Ainat Beniaminovitz ◽  
Helen Hauff ◽  
Katherine Lietz ◽  
David Cohen

Sign in / Sign up

Export Citation Format

Share Document